These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4076751)

  • 21. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
    Schatz C; von Lieven H; Mulders M; Rowold J; Stracke H; Müller H; Grebe SF; Schatz H
    Wien Klin Wochenschr; 1985 Dec; 97(23):873-9. PubMed ID: 3878042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer.
    Tondini C; Hayes DF; Gelman R; Henderson IC; Kufe DW
    Cancer Res; 1988 Jul; 48(14):4107-12. PubMed ID: 3164256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma DNA is more reliable than carcinoembryonic antigen for diagnosis of recurrent esophageal cancer.
    Banki F; Yacoub WN; Hagen JA; Mason RJ; Ayazi S; DeMeester SR; Lipham JC; Danenberg K; Danenberg P; DeMeester TR
    J Am Coll Surg; 2008 Jul; 207(1):30-5. PubMed ID: 18589358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour markers CEA and CA 15-3 as Prognostic factors in breast cancer--univariate and multivariate analysis.
    Ebeling FC; Schmitt UM; Untch M; Nagel D; Fateh-Moghadam A; Stieber P; Seidel D
    Anticancer Res; 1999; 19(4A):2545-50. PubMed ID: 10470192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum.
    Lunde OC; Havig O
    Acta Chir Scand; 1982; 148(2):189-93. PubMed ID: 7148317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [CA 15-3 and CEA as tumor markers in the diagnosis of the recurrence of breast cancer].
    Engel K; Schmid H; Hanke J; Kaufmann M; Müller A
    Geburtshilfe Frauenheilkd; 1988 May; 48(5):309-12. PubMed ID: 3165077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tissue CEA as a prognostic factor in advanced and recurrent breast cancers].
    Tsukikawa S; Kubota S; Biwata T; Shimomura T; Ohyama I; Nagashima T; Kanasugi K; Fukuda M; Yamaguchi S; Maruyama Y
    Gan No Rinsho; 1986 Aug; 32(9):961-4. PubMed ID: 3747160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cystosarcoma phylloides of the breast. A retrospective analysis of 12 cases].
    Mallebré B; Ebert A; Perez-Cantó A; Hopp H; Opril F; Weitzel H
    Geburtshilfe Frauenheilkd; 1996 Jan; 56(1):35-40. PubMed ID: 8852784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity of serum tumor markers CEA and CA 15-3 in breast cancer recurrences and correlation with different prognostic factors.
    Lumachi F; Brandes AA; Ermani M; Bruno G; Boccagni P
    Anticancer Res; 2000; 20(6C):4751-5. PubMed ID: 11205212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Does primary tumor affect the prognosis in postmastectomy locoregional recurrence in breast carcinoma?].
    Willner J; Kiricuta IC; Kölbl O
    Strahlenther Onkol; 1995 Jan; 171(1):18-28. PubMed ID: 7839301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
    Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
    Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical value of CEA and CA125 regarding relapse and metastasis in resectable non-small cell lung cancer.
    Gaspar MJ; Diez M; Rodriguez A; Ratia T; Martin Duce A; Galvan M; Granell J; Coca C
    Anticancer Res; 2003; 23(4):3427-32. PubMed ID: 12926084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer].
    Krieger G; Wander HE; Prangen M; Bandlow G; Beyer JH; Nagel GA
    Dtsch Med Wochenschr; 1983 Apr; 108(16):610-4. PubMed ID: 6839982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Status of skeletal scintigraphy, lung roentgen image and liver sonography in the follow-up of breast cancer].
    Schünemann H
    Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):379-84. PubMed ID: 2661306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Our experience with the diagnostic and prognostic unreliability of pre- and postoperative CEA in human breast cancer].
    Ovaleo-Pandolfo E; Capelli P; Franciosi V
    Acta Biomed Ateneo Parmense; 1985; 56(2):91-8. PubMed ID: 2930984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Carcinoembryonic antigen (CEA) (author's transl)].
    Staab HJ; Anderer FA; Stumpf E; Fischer R
    Dtsch Med Wochenschr; 1977 Jul; 102(30):1082-6. PubMed ID: 891389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serial tests of carcinoembryonic antigen in patients with breast cancer.
    Lee YT
    Am J Clin Oncol; 1983 Jun; 6(3):287-93. PubMed ID: 6846246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carcinoembryonic antigen as a monitor of recurrent breast cancer.
    Lee YT
    J Surg Oncol; 1982 Jun; 20(2):109-14. PubMed ID: 7078191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of carcinoembryonic antigen in the postmastectomy follow-up of primary breast cancer and in the prognostic evaluation of disseminated breast cancer.
    Palazzo S; Liguori V; Molinari B; Greco LM; Mancini V
    Tumori; 1984 Feb; 70(1):57-9. PubMed ID: 6710608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients.
    Molina R; Zanón G; Filella X; Moreno F; Jo J; Daniels M; Latre ML; Giménez N; Pahisa J; Velasco M
    Breast Cancer Res Treat; 1995; 36(1):41-8. PubMed ID: 7579505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.